The advent of GLP-1 receptor agonists—such as semaglutide (Wegovy, Ozempic) and tirzepatide (Zepbound)—has fundamentally rewritten the script for medical weight loss. For decades, the mantra was “eat less, move more.” However, once you are on these medications, “eating less” happens almost automatically. The challenge shifts from a battle of willpower to a strategy of precision.

When your “food noise” is silenced and your appetite is significantly suppressed, the traditional rules of dieting no longer apply. You are no longer trying to restrict calories; you are trying to ensure that the limited calories you do consume are high-quality enough to sustain your metabolic health. On a GLP-1, every bite must count.

The Protein Priority: Your Shield Against Muscle Loss

The most significant risk associated with rapid weight loss on GLP-1 medications is sarcopenia, or the loss of lean muscle mass. When the body is in a steep caloric deficit, it … READ MORE ...